N-(Benzo[d]thiazol-2-yl)-2-chloro-N-ethylacetamide

Catalog No. :
ACPREG084
CAS No. :
852399-70-3
Molecular Formula :
C11H11ClN2OS
Molecular Weight :
254.74

IUPAC Name:N-(benzo[d]thiazol-2-yl)-2-chloro-N-ethylacetamide

N-(Benzo[d]thiazol-2-yl)-2-chloro-N-ethylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$70.00Login to see priceInquiryInquiry
250mg95%$93.00Login to see priceInquiryInquiry
1g95%$230.00Login to see priceInquiryInquiry
5g95%$634.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Benzo[d]thiazol-2-yl)-2-chloro-N-ethylacetamide
IUPAC NameN-(benzo[d]thiazol-2-yl)-2-chloro-N-ethylacetamide
MDL No.MFCD06655537
Molecular FormulaC11H11ClN2OS
Molecular Weight254.74
SMILESO=C(N(C1=NC2=CC=CC=C2S1)CC)CCl
InChI KeyXHZMFHWLTWEYOK-UHFFFAOYSA-N
SynonymN-1,3-BENZOTHIAZOL-2-YL-2-CHLORO-N-ETHYLACETAMIDE;Acetamide, N-2-benzothiazolyl-2-chloro-N-ethyl-;N-2-Benzothiazolyl-2-chloro-N-ethylacetamide
CAS No.852399-70-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPREG084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPREG084 route product structure diagram
    ACPREG084852399-70-3
Inquiry

2. ACPREG084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPREG084 route product structure diagram
    ACPREG084852399-70-3
Inquiry

Comments (0)